Remote Postconditioning in Patients With Acute Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention (PCI) (RemPostCon)

August 16, 2012 updated by: Maurizio Ferrario, IRCCS Policlinico S. Matteo

Pilot Study to Test Feasibility, Safety, Molecular Mediators and Preliminary Efficacy of Remote Myocardial Postconditioning Provided With Extrinsic Cuff Compression of Lower Limb During Primary PCI

Background: Experimental studies suggest that remote limb ischaemic postconditioning (RemPostCon) can reduce infarct size in pigs. Initial clinical applications support the beneficial role of RemPostCon in preserving endothelial function during upper limb ischemia in healthy volunteers and in patients with stable coronary artery disease.

Aim of the study: To evaluate the feasibility, safety and efficacy of RemPostCon in the setting of STEMI and primary PCI (pPCI) and to investigate potential circulating mediators of its effects.

Patients and methods: Patients who undergo pPCI for anterior STEMI within 6 hours since the onset of symptoms are randomly assigned to receive either RemPostCon + pPCI or pPCI alone in a single-blind fashion. All patients receive therapy according to the current international guidelines. Three cycles of ischemia-reperfusion are provided to the lower limb inflating a cuff to 200 mmHg. Each cycle consists of 5' of ischaemia, followed by 5' of reperfusion. RemPostCon is started at the time of angioplasty in the infarct related artery. Primary endpoint is the area under the curve (AUC) of creatinine kinase - MB (CK - MB). Cardiac magnetic resonance (CMR) is performed early before discharge and 4 months after the event, if there are no contraindications.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

96

Phase

  • Phase 2
  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Genoa, Italy, 16100
        • ASL3 Genovese, Villa Scassi Hospitale
      • Pavia, Italy, 27100
        • IRCCS Policlinico San Matteo

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age >= 18 yrs AND Age =< 80 yrs
  • STEMI definition
  • Pain to door time < 6 hrs
  • Killip class 1 - 2 - 3
  • Initial TIMI flow 0 - 1 in the anterior descending artery
  • Signed informed consent

Exclusion Criteria:

  • Pregnancy
  • Cardiogenic shock
  • Initial TIMI flow 2 - 3 in the anterior descending artery
  • History of prior MI in the past 6 months
  • History of prior CABG
  • History of peripheral vascular disease III - IV grade
  • History of abdominal Aortic Aneurysm > 5 cm
  • Severe coronaropathy that could condition further revascularization before the end of the study
  • Other relevant medical or surgical conditions that can influence prognosis at 4 months

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: RemotePostConditioning
Patients will receive pPCI and treatments according to guidelines for STEMI PLUS extrinsic cuff compression to the lower limb for 5 ' followed by 5' reperfusion for three cycles (30' in total) starting with myocardial reperfusion
Lower limb compression using a cuff inflated to 200 mmHg for 5 ' followed by 5' of reperfusion fo three times during 30'
Sham Comparator: Controls
pPCI and treatments according to guidelines for STEMI
Lower limb compression using a cuff inflated to 200 mmHg for 5 ' followed by 5' of reperfusion fo three times during 30'

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Area Under the Curve of CK - MB release
Time Frame: baseline to 72h since admission
baseline to 72h since admission

Secondary Outcome Measures

Outcome Measure
Time Frame
Area Under the Curve of CK release
Time Frame: baselinte to 72h since admission
baselinte to 72h since admission
TIMI Frame Count
Time Frame: 30 minutes after first balloon inflation in infarct-related artery
30 minutes after first balloon inflation in infarct-related artery
Time to balloon
Time Frame: during pPCI
during pPCI
Ejection Fraction MRI
Time Frame: before discharge and after 4 months
before discharge and after 4 months
Myocardial Blush grading
Time Frame: 30 minutes after first balloon inflation
30 minutes after first balloon inflation
ST segment resolution
Time Frame: 6h after balloon
6h after balloon
Troponin I peak
Time Frame: 72h since admission
72h since admission
Mortality rate
Time Frame: 4 months since admission
4 months since admission
artero-venous differences in pO2, pCO2, pH, HCo3
Time Frame: baseline and 30 minutes after first balloon inflation
baseline and 30 minutes after first balloon inflation
Major adverse cardiac events
Time Frame: 4 months since admission
4 months since admission
artero-venous quantitative and qualitative differences in endothelial progenitors cells (subgroups)
Time Frame: within 24 h since admission
within 24 h since admission
artero-venous Differences of Cytokines
Time Frame: within 24h since admission
within 24h since admission
Edema Volume T2 sequences MRI
Time Frame: before discharge
before discharge
Delay enhancement volume MRI
Time Frame: before discharge and after 4 months
before discharge and after 4 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Maurizio Ferrario, MD, IRCCS Policlinico San Matteo
  • Principal Investigator: Gabriele Crimi, MD, IRCCS Policlinico San Matteo

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2009

Primary Completion (Actual)

May 1, 2012

Study Completion (Actual)

May 1, 2012

Study Registration Dates

First Submitted

March 18, 2009

First Submitted That Met QC Criteria

March 18, 2009

First Posted (Estimate)

March 19, 2009

Study Record Updates

Last Update Posted (Estimate)

August 17, 2012

Last Update Submitted That Met QC Criteria

August 16, 2012

Last Verified

August 1, 2012

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Myocardial Infarction

Clinical Trials on Remote Postconditioning

3
Subscribe